Owner Schering Corporation

Inventors Oppmann, Birgit; Malefyt, Rene De Waal; Rennick, Donna M.; Kastelein, Robert A.; Wiekowski, Maria T.; Lira, Sergio A.; Narula, Satwant K.

Agent Griffith Hack

Pub. Number AU-B-2008240348

Parent 2005202420

Filing date 31 October 2008

Wipo publication date 27 November 2008

Acceptance publication date 12 July 2012

C07K 14/54 Peptides having more than 20 amino acids

A61K 38/00 Medicinal preparations containing peptides

A61K 39/39 Medicinal preparations containing antigens or antibodies - characterised by the immunostimulating additives, e.g. chemical adjuvants

A61K 45/00 Medicinal preparations containing active ingredients not provided for in groups

A61P 25/04 Drugs for disorders of the nervous system

A61P 29/00 Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 31/12 Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 35/00 Antineoplastic agents

A61P 37/08 Drugs for immunological or allergic disorders

C07K 16/46 Immunoglobulins, e.g. monoclonal or polyclonal antibodies - Hybrid immunoglobulins

C07K 19/00 Hybrid peptides

C12N 1/15 Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/19 Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/21 Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 5/10 Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 15/09 Mutation or genetic engineering - Recombinant DNA-technology

C12Q 1/02 Measuring or testing processes involving enzymes or micro-organisms - involving viable micro-organisms